Adjusted earnings of 86 cents topped estimates of 76 cents and revenue reached $2.02 billion. The stock gave up a premarket gain of nearly 4% as Unilever, which is buying the spice maker, also declined.
For most companies, a 13% earnings beat would set the day's direction. McCormick is not most companies right now.
The spice and flavor maker reported adjusted earnings of 86 cents a share for its fiscal third quarter on Thursday, against the 76 cents analysts expected. Revenue was $2.02 billion, ahead of the $1.98 billion forecast. That is a beat of about 13% on earnings and about 2% on sales.
The shares rose nearly 4% before the opening bell. By early afternoon they were down about 2.3% at roughly $45.35. Unilever, which agreed to acquire McCormick, fell about 2% over the same session.
Why the target trades differently
A company that has agreed to be acquired trades largely on the terms of the deal and the odds that it closes, not on its own quarterly results. Strong earnings can still matter at the margin, since they reduce the chance that an acquirer seeks to renegotiate and support the value of the business if the deal falls apart. McCormick's moves on Thursday ran alongside Unilever's.
What the quarter shows
The beat came in the middle of a cost environment that has hurt other food companies. Manufacturers in Thursday's national factory survey cited tariffs and petroleum-based materials as drivers of a jump in prices paid, and packaged-food peer Conagra moved its own cost outlook to the top of its range this week. McCormick's sales still came in ahead of forecasts.
Two readings
One reading is that the quarter strengthens the deal's footing. A target beating forecasts by double digits gives Unilever's shareholders less reason to question the price and McCormick's holders a firmer floor if anything goes wrong.
A second reading is that the results change little for investors now. With the stock tied to its acquirer, the quarter matters less than the closing timeline and Unilever's own share price.
What remains
Regulatory milestones and the closing date are the events that will move McCormick's shares from here. Unilever's own trading, and any change in the timetable, matter more to the stock than the next quarterly report.